Dr. Jing Chen, an assistant professor at Emory University, received a $720,000 award from the American Cancer Society to study new drug targets for multiple myeloma.

"This award will help us to extend our work finding and validating critical signaling effectors that could be therapeutic targets in the future,” said Chen.

Last year, Chen and his laboratory discovered the role of a key signaling protein, known as RSK2 (Ribosomal S6 kinase 2), in multiple myeloma cells. They found that if this protein is inhibited or destroyed, certain types …